Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allvivo Vascular
Lake Forest, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ProteoGuard-coated stents completed pre-clinical evaluation and are poised for First in Man trial. The company has also demonstrated in vitro feasibility for an antibacterial coated catheter with preclinical development ongoing. Lead antimicrobial peptide technologies (ASP-1 and ASP-2) have shown potent, biofilm-active, and resistance-limiting activity in vitro.
- Therapeutic areas
- CardiovascularInfectious Diseases
- Modalities
- Antimicrobial peptidesBiologicCoatingDrug delivery
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on Allvivo Vascular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allvivo Vascular.